Your Web Site
Compiled from Herald News Services Published:Â Friday, October 10, 2008 A group of American investors has launched a class-action lawsuit against drug maker Biovail Corp., alleging the company and some executives made misleading statements during the approval process for the anti-depressant... [read full story]
